Literature DB >> 3942148

Treatment of temporal arteritis with ocular involvement.

S I Rosenfeld, G S Kosmorsky, T G Klingele, R M Burde, E M Cohn.   

Abstract

A 78-year-old white woman had catastrophic visual loss in one eye due to temporal arteritis. Despite treatment with doses of oral corticosteroids high enough to normalize the Westergren erythrocyte sedimentation rate, she experienced progressive retinal ischemia with visual loss in the second eye. The use of 1,000 mg of pulsed intravenous methylprednisolone every 12 hours restored her vision. Brief hospitalization of patients with arteritic ischemic optic neuropathy for treatment with intravenous methylprednisolone may offer a significant chance of visual recovery of the involved eye and provide optimal protection to the uninvolved eye.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942148     DOI: 10.1016/0002-9343(86)90066-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Treatable blindness in temporal arteritis.

Authors:  L Clearkin
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

2.  Prolonged corticosteroid treatment in the management of temporal arteritis.

Authors:  G Friedman; B Friedman
Journal:  Klin Wochenschr       Date:  1988-12-01

3.  Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.

Authors:  M J Kupersmith; R Langer; H Mitnick; R Spiera; H Spiera; M Richmond; S Paget
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

Review 4.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

5.  Giant Cell Arteritis.

Authors:  Jennifer K. Hall; Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

6.  Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

Authors:  G Delecoeuillerie; P Joly; A Cohen de Lara; J B Paolaggi
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

7.  Treatable blindness in temporal arteritis.

Authors:  J P Diamond
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

Review 8.  Epidemiology and optimal management of polymyalgia rheumatica.

Authors:  P Labbe; P Hardouin
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

9.  Development of an evidence-based regimen of prednisolone to treat giant cell arteritis - the Norwich regimen.

Authors:  Chetan Mukhtyar; Heidi Cate; Conor Graham; Peter Merry; Karen Mills; Aseema Misra; Colin Jones
Journal:  Rheumatol Adv Pract       Date:  2019-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.